November 28, 2014 2:54 PM ET


Company Overview of Roche Glycart AG

Company Overview

Roche Glycart AG, a biotechnology company, engages in the research, development, and commercialization of antibody-based products for the treatment of cancer and autoimmune diseases in Switzerland. The company develops antibody drug candidates, which include GA101, a humanized anti-CD20 monoclonal antibody to increase direct- and immune-mediated target cell death; and GA201, a humanized glycoengineered antibody for solid tumors. Roche Glycart AG was formerly known as GLYCART Biotechnology AG and changed its name to Roche Glycart AG on January 1, 2010. The company was founded in 2000 and is headquartered in Schlieren, Switzerland. As of July 25, 2005, Roche Glycart AG operates as a subsidiary...

Wagistrasse 18

Schlieren,  8952


Founded in 2000


41 44 755 61 61


41 44 755 61 60

Key Executives for Roche Glycart AG

Co-Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Gene Signal International SA Europe
MykoGreen Biotechnology AG Europe
AnTeq AG Europe
Isolagen International S.A. Europe
Glaxo Institute for Molecular Biology Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Roche Glycart AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at